Search

Your search keyword '"Eriksen, Erik Fink"' showing total 22 results
Start Over Author "Eriksen, Erik Fink" Publisher wiley
22 results on '"Eriksen, Erik Fink"'

2. Leif Mosekilde

Author

Rejnmark, Lars, primary, Brixen, Kim, additional, Kassem, Moustapha, additional, Hermann, Pernille, additional, Vestergaard, Peter, additional, Eriksen, Erik Fink, additional, Bollerslev, Jens, additional, Nielsen, Henning K, additional, Charles, Peder, additional, and Langdahl, Bente, additional

Published
2018
Full Text
View/download PDF

7. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis

Author

Cosman, Felicia, primary, Eriksen, Erik Fink, additional, Recknor, Chris, additional, Miller, Paul D, additional, Guañabens, Núria, additional, Kasperk, Christian, additional, Papanastasiou, Philemon, additional, Readie, Aimee, additional, Rao, Hanumantha, additional, Gasser, Jürg A, additional, Bucci-Rechtweg, Christina, additional, and Boonen, Steven, additional

Published
2011
Full Text
View/download PDF

9. Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older

Author

Boonen, Steven, primary, Black, Dennis M., additional, Colón-Emeric, Cathleen S., additional, Eastell, Richard, additional, Magaziner, Jay S., additional, Eriksen, Erik Fink, additional, Mesenbrink, Peter, additional, Haentjens, Patrick, additional, and Lyles, Kenneth W., additional

Published
2010
Full Text
View/download PDF

12. Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture

Author

Eriksen, Erik Fink, primary, Lyles, Kenneth W, additional, Colón-Emeric, Cathleen S, additional, Pieper, Carl F, additional, Magaziner, Jay S, additional, Adachi, Jonathan D, additional, Hyldstrup, Lars, additional, Recknor, Chris, additional, Nordsletten, Lars, additional, Lavecchia, Catherine, additional, Hu, Huilin, additional, Boonen, Steven, additional, and Mesenbrink, Peter, additional

Published
2009
Full Text
View/download PDF

13. Long‐Term Control of Bone Turnover in Paget's Disease With Zoledronic Acid and Risedronate

Author

Hosking, David, primary, Lyles, Kenneth, additional, Brown, Jacques P, additional, Fraser, William D, additional, Miller, Paul, additional, Curiel, Manuel Diaz, additional, Devogelaer, Jean‐Pierre, additional, Hooper, Michael, additional, Su, Guoqin, additional, Zelenakas, Ken, additional, Pak, Judy, additional, Fashola, Taiwo, additional, Saidi, Youssef, additional, Eriksen, Erik Fink, additional, and Reid, Ian R, additional

Published
2007
Full Text
View/download PDF

16. Differential Effects of Teriparatide and Alendronate on Bone Remodeling in Postmenopausal Women Assessed by Histomorphometric Parameters

Author

Arlot, Monique, primary, Meunier, Pierre J, additional, Boivin, Georges, additional, Haddock, Lillian, additional, Tamayo, Juan, additional, Correa-Rotter, Ricardo, additional, Jasqui, Salomón, additional, Donley, David W, additional, Dalsky, Gail P, additional, Martin, Javier San, additional, and Eriksen, Erik Fink, additional

Published
2005
Full Text
View/download PDF

22. Excessive decrease in serum magnesium after total thyroidectomy for Graves' disease is related to development of permanent hypocalcemia.

Author

Hammerstad SS, Norheim I, Paulsen T, Amlie LM, and Eriksen EF

Subjects
Adult, Biomarkers blood, Calcium blood, Female, Follow-Up Studies, Graves Disease blood, Humans, Hypocalcemia blood, Hypocalcemia diagnosis, Hypoparathyroidism blood, Hypoparathyroidism diagnosis, Hypoparathyroidism etiology, Male, Middle Aged, Parathyroid Hormone blood, Phosphates blood, Postoperative Complications blood, Postoperative Complications diagnosis, Risk Factors, Graves Disease surgery, Hypocalcemia etiology, Magnesium blood, Postoperative Complications etiology, Thyroidectomy
Abstract

Background: Transient postoperative hypocalcemia is one of the most common complications after thyroidectomy. Permanent hypocalcemia, however, is rare, but usually requires life-long treatment and follow-up. The risk of permanent hypocalcemia has been shown to be significantly higher in patients with Graves' disease. In the present study we evaluated short-term and long-term changes in serum calcium, phosphate, magnesium, and parathyroid hormone (PTH) levels in order to characterize subjects at risk of postoperative hypoparathyroidism., Methods: Forty patients who underwent total thyroidectomy for Graves' disease were included in the study. Calcium, phosphate, magnesium, and PTH were measured before surgery and regularly during the year that followed., Results: Postoperative hypocalcemia was seen in 21/40 (53 %) patients. Undetectable PTH (<0.6 pmol/L) was registered in 11/40 (27 %) patients. All patients with measurable PTH 6-48 h after operation regained normal calcium. Of those with undetectable PTH after 6-48 h, four developed permanent hypocalcemia. We found a significantly lower serum calcium level before operation in patients who developed permanent hypocalcemia compared to those who did not (p < 0.001). We also found a significant correlation between the decrease in serum magnesium from time 0 to 48 h after operation and permanent hypocalcemia (p = 0.015)., Conclusions: Serum calcium prior to operation, serum PTH, and degree of decrease in magnesium levels in serum 48 h after operation may predict development of permanent hypocalcemia. Magnesium plays an important role in calcium homeostasis via stimulation of PTH secretion and modulation of PTH receptor sensitivity. Both mechanisms may have played a role for the findings reported in this article.

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results